ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,000 | -20.0% | 90 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $5,000 | -16.7% | 90 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | 0.0% | 90 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $6,000 | +100.0% | 90 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $3,000 | 0.0% | 90 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $3,000 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |